{
"id":"mk19_a_np_q075",
"number":75,
"bookId":"np",
"correctAnswer":"C",
"title":"Question 75",
"stimulus":[
{
"type":"p",
"hlId":"a21681",
"children":[
"A 48-year-old man is evaluated in the emergency department for sudden onset of dyspnea. He has a 2-week history of progressive leg edema and bilateral flank pain. He has no other medical problems and takes no medications."
]
},
{
"type":"p",
"hlId":"e242b0",
"children":[
"On physical examination, respiratory rate is 26/min; other vital signs are normal. There is 2-mm pitting edema in the lower extremities to the mid-shin bilaterally. The remainder of the examination is unremarkable."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"4590ed",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Protein, Albumin, serum",
"children":[
"Albumin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"3f2cc2",
"class":"cell text l",
"children":[
"2.0 g/dL (20 g/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"182194",
"class":"cell text l",
"children":[
"Total cholesterol"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"7010db",
"class":"cell text l",
"children":[
"401 mg/dL (10.4 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"42bd12",
"class":"cell text l",
"children":[
"Complement levels"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"960b44",
"class":"cell text l",
"children":[
"Normal"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f461b2",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Creatinine, serum",
"children":[
"Creatinine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"0f19a0",
"class":"cell text l",
"children":[
"1.1 mg/dL (97.2 µmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"b534b1",
"class":"cell text l",
"children":[
"Antinuclear antibodies"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"ffb935",
"class":"cell text l",
"children":[
"Negative"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"747c2a",
"class":"cell text l",
"children":[
"Urinalysis"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"55b2c1",
"class":"cell text l",
"children":[
"No blood; 4+ protein; 0-1 erythrocytes/hpf; 0-1 leukocytes/hpf"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"d17af8",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Protein-creatinine ratio, urine",
"children":[
"Urine protein-creatinine ratio"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"291dc1",
"class":"cell text l",
"children":[
"8900 mg/g"
]
}
]
}
]
}
]
}
]
},
{
"type":"p",
"hlId":"9652c4",
"children":[
"Hepatitis B and C, HIV, and syphilis testing results are negative."
]
},
{
"type":"p",
"hlId":"c91ab5",
"children":[
"CT of the chest shows segmental pulmonary embolism. CT of the abdomen and pelvis shows bilateral renal vein thromboses."
]
},
{
"type":"p",
"hlId":"827877",
"children":[
"Low-molecular-weight heparin is initiated."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"ab9d96",
"children":[
"Which of the following is the most appropriate diagnostic test to perform next?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"ANCA antibodies"
}
},
{
"letter":"B",
"text":{
"__html":"Anti–double-stranded DNA antibodies"
}
},
{
"letter":"C",
"text":{
"__html":"Anti-phospholipase A2 receptor antibodies"
}
},
{
"letter":"D",
"text":{
"__html":"Kidney biopsy following discontinuation of heparin"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"b65263",
"hvc":true,
"children":[
"Serologic testing for anti-phospholipase A2 receptor antibodies is a noninvasive test that approaches 100% specificity for primary membranous nephropathy."
]
},
{
"type":"keypoint",
"hlId":"078cc9",
"hvc":true,
"children":[
"Serologic testing for anti-phospholipase A2 receptor antibodies can eliminate the need for kidney biopsy in patients with preserved kidney function and no evidence of secondary causes as well as in patients with a clear contraindication to kidney biopsy."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"c5a437",
"children":[
"Anti-phospholipase A2 receptor (PLA2R) antibody (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
") testing is the most appropriate diagnostic test to perform next. This patient with the nephrotic syndrome and venous thromboembolism most likely has membranous nephropathy. Patients with membranous nephropathy are particularly prone to thrombotic complications. These clots include lower extremity, pulmonary, and renal vein thromboses; they can occur in up to 25% of patients and are most likely to occur within the first 6 months of diagnosis. The risk for clotting increases when serum albumin is <2.8 g/dL (28 g/L) and increases proportionally with decreasing serum albumin levels. The diagnosis of primary membranous nephropathy can be made noninvasively using serum anti-PLA2R antibody testing. Anti-PLA2R antibodies are nearly 100% specific for primary membranous nephropathy and can obviate the need for kidney biopsy in patients with preserved kidney function and no evidence of secondary causes as well as in patients with a clear contraindication to kidney biopsy."
]
},
{
"type":"p",
"hlId":"7a3463",
"children":[
"ANCA-associated vasculitis typically presents as a rapidly progressive glomerulonephritis characterized by a rapid decline in kidney function and erythrocytes and erythrocyte casts on urine microscopy. These findings are not present in this patient; therefore, ANCA antibody testing (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
") is not appropriate."
]
},
{
"type":"p",
"hlId":"841931",
"children":[
"Anti–double-stranded DNA antibodies (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
") are highly specific in establishing the diagnosis of systemic lupus erythematosus. Although class V lupus nephritis is a cause of secondary membranous nephropathy, normal complement levels and negative antinuclear antibody testing rule out lupus nephritis."
]
},
{
"type":"p",
"hlId":"20ae77",
"children":[
"Stopping anticoagulation to perform a kidney biopsy (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
") in this patient with venous thromboembolism is high risk; therefore, the next step in management should be anti-PLA2R testing, which, if positive, is a definitive diagnosis of membranous nephropathy."
]
}
],
"relatedSection":"mk19_a_np_s6_3_3_3",
"objective":{
"__html":"Diagnose membranous nephropathy using noninvasive testing."
},
"references":[
[
"Bobart SA, De Vriese AS, Pawar AS, et al. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int. 2019;95:429-38. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30665573",
"target":"_blank"
},
"children":[
"PMID: 30665573"
]
},
" doi:10.1016/j.kint.2018.10.021"
]
],
"hospitalist":false,
"hvc":true,
"peerComparison":{
"A":4,
"B":4,
"C":60,
"D":32,
"E":0
},
"hlIds":[
"a21681",
"e242b0",
"a462a3",
"4590ed",
"3f2cc2",
"182194",
"7010db",
"42bd12",
"960b44",
"f461b2",
"0f19a0",
"b534b1",
"ffb935",
"747c2a",
"55b2c1",
"d17af8",
"291dc1",
"9652c4",
"c91ab5",
"827877",
"ab9d96",
"b65263",
"078cc9",
"c5a437",
"7a3463",
"841931",
"20ae77"
]
}